Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer-Reference-Cited by-同舟云学术

Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer

Published:2019-10-23 Issue:18 Volume:8 Page:7728-7740
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shang Song¹,Wang Jinfeng¹,Chen Shilin¹,Tian Renyun²,Zeng Hui³,Wang Liang³,Xia Man⁴,Zhu Haizhen²,Zuo Chaohui¹^ORCID

Affiliation:

1. Department of Gastroduodenal and Pancreatic Surgery Translational Medicine Research Center of Liver Cancer Laboratory of Digestive Oncology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Hunan Cancer Hospital Changsha China

2. Department of Molecular Medicine College of Biology State Key Laboratory of Chemo/Biosensing and Chemometrics Hunan University Changsha China

3. Graduates School University of South China Hengyang China

4. Department of Gynecological Oncology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Hunan Cancer Hospital Changsha China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2633

Reference51 articles.

1. Cancer statistics in China, 2015

2. Cancer statistics, 2014

3. Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)